Adaptimmune Therapeutics plc (ADAPY)
OTCMKTS · Delayed Price · Currency is USD
0.0261
-0.0026 (-9.06%)
At close: Oct 29, 2026
Adaptimmune Therapeutics Market Cap
Adaptimmune Therapeutics has a market cap or net worth of $6.92 million as of October 30, 2026. It is the 43,356th most valuable company in the world and the 5,795th biggest in the United States. Its market cap has decreased by 51.58% in one year.
Market Cap
6.92M
Enterprise Value
-4.95M
Revenue
5.92M
Global Rank
Country Rank
#5,795 United States
PE Ratio
0.33
ChartMarket Cap Chart
Since May 7, 2015, Adaptimmune Therapeutics's market cap has decreased from 1.22B to 6.92M, a decrease of -99.43%. That is a compound annual growth rate of -36.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 6.92M | 0.38% |
| Dec 31, 2025 | 6.89M | -95.00% |
| Dec 31, 2024 | 137.84M | -23.47% |
| Dec 29, 2023 | 180.11M | -24.70% |
| Dec 30, 2022 | 239.19M | -59.17% |
| Dec 31, 2021 | 585.77M | -29.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zeo ScientifiX | 10.66M |
| Anebulo Pharmaceuticals | 9.86M |
| EOM Pharmaceuticals Holdings | 9.49M |
| Oncotelic Therapeutics | 8.46M |
| VitaSpring Biomedical | 6.58M |
| TRON Group | 6.11M |
| Curative Biotechnology | 5.93M |
| Eastgate Biotech | 5.29M |